×

Parexel to be acquired by Pamplona Capital for $5 billion

9:29 AM ET Tue, 20 June 2017

Biopharmaceutical company Parexel confirmed Tuesday morning it will be acquired by Pamplona Capital for $88.10 per share in cash, in a transaction valued at approximately $5 billion.